AHR changes
Pick any two versions below to diff them.
- Price
- $57.57
- Discount category
- Pricey
- Intrinsic value source
- AI estimate
- Next earnings
- Feb 5, 2027
- Next earnings is estimate
- Yes
- Company name
- added: American Healthcare REIT
- Sector
- added: Healthcare REIT
- About
- added: American Healthcare REIT, Inc. (AHR) is based in Irvine, California. It is a real estate investment trust that owns and operates clinical healthcare properties in the United States, the United Kingdom and the Isle of Man. Its four segments are integrated senior health campuses (ISHC), mainly through Trilogy, senior housing operating properties (SHOP), outpatient medical buildings and triple-net leased properties. In the ISHC and SHOP segments it gets the operating income of the properties, not only rent. At September 30, 2026, it owned or operated 366 buildings and ISHC, with about 25.4 million square feet and a total contract purchase price of $7.4 billion. The common stock trades on the NYSE in US dollars. American Healthcare REIT files 10-K and 10-Q reports.
- Thesis
- added: The market pays close to the AI estimate for American Healthcare REIT because it expects the fast growth in senior housing income to continue, while the company sells many new shares to buy more properties. Total portfolio same-store NOI grew 13.8% in Q3 2026, with 28.2% in SHOP and 15.7% in ISHC, and NFFO was $0.58 per diluted share. At November 5, 2026, forward sales of 24.6 million shares, about $1.32 billion, were not yet settled, and the investment pipeline was more than $1.0 billion. For the value to rise, three things must be true. Occupancy and rates must keep rising, so that same-store NOI grows at double digits in 2027. New acquisitions must add to NFFO per share after the new shares. Medicare and Medicaid rates for skilled nursing must not fall. The Q4 2026 report with 2027 guidance, expected in early February 2027, is the next test. If senior housing growth slows, the high multiple of NFFO in the price can fall.
- Valuation
- added: The intrinsic value for American Healthcare REIT is an AI estimate from November 14, 2026. It is not an analyst's value. An AI research agent calculated it from the filings of American Healthcare REIT with the SEC. The method is a multiple of 2027 normalized funds from operations (NFFO) per diluted share. NFFO is after interest, so the estimate makes no separate debt adjustment. The Q4 2025 release (8-K, February 26, 2026) gives 2025 NFFO of $1.72 per diluted share. The Q3 2026 release (8-K, November 5, 2026) gives Q3 NFFO of $126.6 million, or $0.58 per diluted share on 217,711,583 diluted weighted shares, and $1.64 per diluted share for nine months. It raises 2026 guidance to NFFO of $2.23 to $2.26 per diluted share and total portfolio same-store NOI growth of 12.0% to 14.0%. It gives unsettled forward sale agreements for 24,598,011 shares, or about $1.32 billion, at November 5, 2026, and an investment pipeline of more than $1.0 billion. The Form 10-Q for the quarter ended September 30, 2026 gives mortgage loans of $830.8 million in principal, a term loan of $550.0 million due January 19, 2027, and cash of $222.8 million. The cover of the 10-Q gives 232,068,432 shares at November 2, 2026. The estimate assumes that the money from the forward sales goes into new properties with returns close to those of the current portfolio, so NFFO per share already counts the new shares. The 2027 NFFO and the multiples are assumptions. The low case assumes $2.40, because occupancy gains slow and labor costs rise, at 16 times. It gives $38.40 per share. The base case assumes $2.60, from a full year of the 2026 acquisitions and more same-store growth, at 20 times. It gives $52.00 per share. The high case assumes $2.80, from fast senior housing growth and more acquisitions, at 24 times. It gives $67.20 per share. The estimate assumes weights of 25%, 50% and 25%. The weighted intrinsic value is $52.40 per share. American Healthcare REIT works with good regional operators, and its Trilogy campuses combine senior housing and skilled nursing, but other owners can buy or build similar properties, and Medicare and Medicaid rates set part of its income. As of Nov 14, 2026.
- Risks
- added: The SHOP and ISHC segments depend on occupancy, rates and labor costs. Same-store NOI grew 28.2% in SHOP in Q3 2026, and a slowdown would lower the growth of NFFO. The ISHC campuses include skilled nursing, which gets part of its revenue from Medicare and Medicaid. A cut in rates or a change in rules can lower income. The company issues many new shares to buy properties. At November 5, 2026, forward sales of 24,598,011 shares were not yet settled, and a new program for up to $1,750 million started on November 6, 2026. If it pays too much for properties, NFFO per share grows less. A $550.0 million term loan is due on January 19, 2027, and it cannot be extended. The company changed its Chief Executive Officer and Chief Financial Officer in 2026, after the former Chief Executive Officer took a medical leave in February 2026.
- Balance sheet
- added: Cash: $223M Debt: $1.4B Net debt: $1.2B Net debt / EBITDA: 1.9× (low) Undrawn credit line: $800M, to April 2030 At September 30, 2026, American Healthcare REIT had cash and cash equivalents of $222.8 million. Debt principal was $1,380.8 million: mortgage loans of $830.8 million with a weighted average effective rate of 3.87%, and a $550.0 million term loan due on January 19, 2027, which cannot be extended. The $800 million of revolving loans in its credit facility had no borrowings and run to April 1, 2030. Total liquidity was about $2.35 billion, including the expected gross proceeds of the unsettled forward sales. Net debt to annualized adjusted EBITDA was 1.9x, down from 2.5x at June 30, 2026. Total equity was $5,582.6 million. As of Sep 30, 2026.
- Checkpoints
- added: Jan 19, 2027: Term loan due. Pending. Watch: The company repays or refinances the $550.0 million term loan on time without a large rise in interest cost, and this passes; a costly refinancing fails. Feb 5, 2027 (estimate): Q4 2026 results and 2027 guidance. Pending. Watch: 2026 NFFO is in the guided range of $2.23 to $2.26 per diluted share and 2027 guidance shows more growth in NFFO per share, and this passes; flat 2027 guidance fails.
- Recent events
- added: Nov 6, 2026: American Healthcare REIT started a new at-the-market equity program for up to $1,750 million of common stock, with sales directly or through forward sale agreements. Nov 5, 2026: American Healthcare REIT reported Q3 2026 results. NFFO was $0.58 per diluted share, total portfolio same-store NOI grew 13.8%, and it bought 17 SHOP properties for about $1.69 billion. It raised 2026 guidance to NFFO of $2.23 to $2.26 per diluted share and same-store NOI growth of 12.0% to 14.0%. Aug 10, 2026: American Healthcare REIT agreed to sell 15,237,500 shares through forward sale agreements in a follow-on offering, for gross proceeds of about $819.0 million. Aug 6, 2026: American Healthcare REIT reported Q2 2026 NFFO of $0.54 per diluted share and same-store NOI growth of 13.2%, and it raised 2026 NFFO guidance to $2.15 to $2.19 per diluted share. Jul 22, 2026: Chairman Jeff Hanson became Chief Executive Officer, Gabe Willhite became President and Chief Operating Officer, and Danny Prosky retired as Chief Executive Officer and stayed a director. Aric Chang later joined as Chief Financial Officer. May 20, 2026: American Healthcare REIT agreed to sell 16,100,000 shares through forward sale agreements in a follow-on offering, for gross proceeds of about $811.4 million. May 7, 2026: American Healthcare REIT reported Q1 2026 NFFO of $0.50 per diluted share, up more than 30%, and it raised 2026 NFFO guidance to $2.03 to $2.09 per diluted share. Apr 1, 2026: American Healthcare REIT amended its credit facility. The revolving loans now mature on April 1, 2030, with options to extend to April 1, 2031, and the $550.0 million term loan still matures on January 19, 2027. Feb 26, 2026: American Healthcare REIT reported 2025 NFFO of $1.72 per diluted share and same-store NOI growth of 14.2%, and it guided 2026 NFFO of $1.99 to $2.05 per diluted share.